Stock 2269 WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
11.14 HKD -0.54% Intraday chart for WuXi Biologics (Cayman) Inc. -10.45% -62.36%
06:56pm US lawmakers ask FBI for briefing on GenScript Biotech's links to China RE
May. 31 US lawmakers ask FBI for briefing on GenScript Biotech's links to China RE

Evolution of the average Target Price on WuXi Biologics (Cayman) Inc.

Price target over the last 5 years

History of analyst recommendation changes

9ba215b470c4d9e655c71fc062e9.mwZ3e17rSrqY0l7EhaduJHlzsvAMHfDlwjWIJhdSTyc.3FUjKjqYB96s5BC34JQnVi83xJFfJJGvlF7CU3AjOWn5cVo2M4IL4_u2Cw~216a5a7957639cbe66e4f29aceea5b31

Analyst Recommendations on WuXi Biologics (Cayman) Inc.

Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3% MT
Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy MT
Hong Kong Stocks Rebound Over Unchanged Fed Rates; Wuxi Up 3% MT
Nomura Adjusts Wuxi Biologics’ Price Target to HK$58.44 From HK$82.69, Keeps at Buy MT
Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy MT
Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy MT
New energy shares drag China stocks lower, Fed rate-decision jitters weigh RE
UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy MT
UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy MT
China stocks rise on higher-than-expected borrowing rate cut; foreign inflows surge RE
UBS Adjusts Wuxi Biologics' Price Target to HK$110.67 From HK$142, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$100.87 From HK$103.28, Keeps at Buy MT
Nomura Adjusts WuXi Biologics' Price Target to HK$103.28 From HK$149.92, Keeps at Buy MT
China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up RE
WUXI BIOLOGICS CAYMAN : Nomura Adjusts WuXi Biologics' Price Target to HK$116.8 From HK$213.1, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
10.32 CNY
Average target price
24.91 CNY
Spread / Average Target
+141.46%
High Price Target
67.84 CNY
Spread / Highest target
+557.61%
Low Price Target
11.08 CNY
Spread / Lowest Target
+7.45%

Consensus detail

Consensus revision (last 18 months)

Analysts covering WuXi Biologics (Cayman) Inc.

Nomura
UBS

Ratings for WuXi Biologics (Cayman) Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. Consensus WuXi Biologics (Cayman) Inc.